相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular and functional characterization of choline transporter in human colon carcinoma HT-29 cells
Hironobu Kouji et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Clinical Applications of Metabolomics in Oncology: A Review
Jennifer L. Spratlin et al.
CLINICAL CANCER RESEARCH (2009)
Quantitative techniques in 18FDG PET scanning in oncology
F. Castell et al.
BRITISH JOURNAL OF CANCER (2008)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Hypoxia regulates choline kinase expression through hypoxia-inducible factor-lot signaling in a human prostate cancer model
Kristine Glunde et al.
CANCER RESEARCH (2008)
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer:: Long-term results of a prospective study
Katja Ott et al.
CLINICAL CANCER RESEARCH (2008)
Changes in tumor metabolism as readout for mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma
Liu Hua Wei et al.
CLINICAL CANCER RESEARCH (2008)
Brick by brick: metabolism and tumor cell growth
Ralph J. DeBerardinis et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Current and potential applications of clinical 13C MR spectroscopy
John Kurhanewicz et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors
Elaine T. Lam et al.
MOLECULAR CANCER THERAPEUTICS (2008)
F-18-fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma
Ester J. M. Siemerink et al.
ONCOLOGIST (2008)
MR spectroscopy of the breast
F. Sardanelli et al.
RADIOLOGIA MEDICA (2008)
The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions
Natalie J. Serkova et al.
PROSTATE (2008)
Warburg revisited: imaging tumour blood flow and metabolism
K. A. Miles et al.
CANCER IMAGING (2008)
Sugar and fat - that's where it's at: metabolic changes in tumors
Christian D. Young et al.
BREAST CANCER RESEARCH (2008)
Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells
Noriko Mori et al.
CANCER RESEARCH (2007)
CT and PET: Early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor
Clay H. Holdsworth et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Cancer imaging with fluorine-18-labeled choline derivatives
Sandi A. Kwee et al.
SEMINARS IN NUCLEAR MEDICINE (2007)
Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer:: a retrospective study
Ana Ramirez de Molina et al.
LANCET ONCOLOGY (2007)
Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non-small-cell lung cancer
John V. Heymach et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status
Tone F. Bathen et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies
Galit Eliyahu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways
Daniel Morvan et al.
CANCER RESEARCH (2007)
From exogenous to endogenous:: The inevitable imprint of mass spectrometry in metabolomics
Elizabeth J. Want et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas
Heidi Lyng et al.
BMC CANCER (2007)
Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role
Hubert Vesselle et al.
CLINICAL CANCER RESEARCH (2007)
A metabolomics perspective of human brain tumours
Julian L. Griffin et al.
FEBS JOURNAL (2007)
Glucose metabolism and cancer
Reuben J. Shaw
CURRENT OPINION IN CELL BIOLOGY (2006)
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease
Lale Kostakoglu et al.
CANCER (2006)
Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors
Carsten Denkert et al.
CANCER RESEARCH (2006)
Choline metabolism in cancer: implications for diagnosis and therapy
Kristine Glunde et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors
Helen Su et al.
CLINICAL CANCER RESEARCH (2006)
Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism
Kristine Glunde et al.
PHARMACOGENOMICS (2006)
Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III
Elena Bonora et al.
CANCER RESEARCH (2006)
Epidermal growth factor receptor biology in head and neck cancer
Shailaja Kalyankrishna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Acid-mediated tumor invasion: a multidisciplinary study
RA Gatenby et al.
CANCER RESEARCH (2006)
Positron emission tomography measurement of tumor metabolism and growth: Its expanding role in oncology
Anthony F. Shields
MOLECULAR IMAGING AND BIOLOGY (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells
M Beloueche-Babari et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models
NMS Al-Saffar et al.
CANCER RESEARCH (2006)
Pattern recognition and biomarker validation using quantitative H-1-NMR-based metabolomics
Natalie J. Serkova et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation
K Glunde et al.
CANCER RESEARCH (2005)
Visualization of a primary anti-tumor immune response by positron emission tomography
CYJ Shu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expanding the use of magnetic resonance in the assessment of tumor response to therapy: Workshop report
J Evelhoch et al.
CANCER RESEARCH (2005)
Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy
M Muruganandham et al.
CLINICAL CANCER RESEARCH (2005)
Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics
K Odunsi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Detection of resistance to imatinib by metabolic profiling - Clinical and drug development implications
N Serkova et al.
AMERICAN JOURNAL OF PHARMACOGENOMICS (2005)
Measuring the metabolome: current analytical technologies
WB Dunn et al.
ANALYST (2005)
Phospholipid biosynthesis in mammalian cells
JE Vance et al.
BIOCHEMISTRY AND CELL BIOLOGY (2004)
Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells
S Gottschalk et al.
CLINICAL CANCER RESEARCH (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
The anti-angiogenic basis of metronomic chemotherapy
RS Kerbel et al.
NATURE REVIEWS CANCER (2004)
Akt stimulates aerobic glycolysis in cancer cells
RL Elstrom et al.
CANCER RESEARCH (2004)
Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report
B Hughes et al.
BMC CANCER (2004)
Metabolite changes in BT4C rat gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death as studied by 1H NMR spectroscopy in vivo, ex vivo, and in vitro
KK Lehtimäki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy
FA Howe et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy
JL Griffin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly
JY Wang et al.
ANTI-CANCER DRUGS (2003)
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
J Tran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging
UG Mueller-Lisse et al.
MAGNETIC RESONANCE IN MEDICINE (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells
SM Ronen et al.
BRITISH JOURNAL OF CANCER (2001)
Metabolic profiling allows comprehensive phenotyping of genetically or environmentally modified plant systems
U Roessner et al.
PLANT CELL (2001)
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
G Klement et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
